Stockscreener 앱 받기
1.44
5.88%
-0.09
전일 마감가:
$1.53
열려 있는:
$1.53
하루 거래량:
468.02K
Relative Volume:
0.13
시가총액:
$50.03M
수익:
-
순이익/손실:
$-10.58M
주가수익비율:
-1.20
EPS:
-1.2
순현금흐름:
$-9.21M
1주 성능:
+3.60%
1개월 성능:
-33.33%
6개월 성능:
+45.45%
1년 성능:
+19.01%
1일 변동 폭
$1.43
$1.535
1주일 범위
$1.34
$1.55
52주 변동 폭
$0.82
$3.38
Microbot Medical Inc Stock (MBOT) Company Profile
명칭
Microbot Medical Inc
전화
908-938-5561
주소
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
MBOT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MBOT
Microbot Medical Inc
|
1.44 | 50.03M | 0 | -10.58M | -9.21M | -1.20 |
|
ISRG
Intuitive Surgical Inc
|
476.78 | 170.05B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
222.79 | 63.97B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
86.81 | 42.94B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
219.72 | 32.28B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
34.55 | 17.64B | 17.28B | 108.00M | 391.00M | 0.20 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-01-13 | 재확인 | H.C. Wainwright | Buy |
| 2019-12-24 | 재확인 | H.C. Wainwright | Buy |
| 2018-01-31 | 개시 | Ladenburg Thalmann | Buy |
Microbot Medical Inc 주식(MBOT)의 최신 뉴스
Microbot Medical Stock Price, Quotes and Forecasts | NASDAQ:MBOT - Benzinga
Microbot Medical names Paul Mullen as VP, sales - Medical Buyer
Microbot Medical Appoints Seasoned Endovascular Sales - GlobeNewswire
Microbot Medical Appoints New VP Ahead of Product Launch - TipRanks
Microbot Medical appoints Paul Mullen as VP, sales - TipRanks
Microbot Medical Appoints Seasoned Endovascular Sales Executive To Lead Its U.S. Sales Activities For LIBERTY® Endovascular Robotic System - MENAFN.COM
Can This Executive From a $4.94B Acquired Company Drive Microbot's Robotic System to Market Success? - StockTitan
Microbot Medical Inc. and Corewell Health Are Working Together to Advance Robotic Telesurgery for Endovascular Applications - Marketscreener.com
Microbot Medical's LIBERTY System Data On Robotic Telesurgery To Be Presented At CRT 2025 - Nasdaq
Microbot Medical Advances in Robotic Telesurgery Research - TipRanks
Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting - The Manila Times
Microbot Medical Inc. and Corewell Health™ Achieve Milestone in Robotic Telesurgery Collaboration - Nasdaq
Robotic Telesurgery Data from Collaboration with Corewell - GlobeNewswire
Can Surgeons Operate From Miles Away? Microbot's Telesurgery Breakthrough Heads to Major Cardiology Conference - StockTitan
Microbot Medical (MBOT) Stock Price, News & Analysis - MarketBeat
Why Microbot Medical Inc. (MBOT) Is Skyrocketing So Far In 2025 - MSN
Microbot Medical Closes $13M Offering for Expansion - TipRanks
Microbot Medical raises funds and anticipates FDA clearance - MSN
Microbot Medical Closes $13 Million Registered Direct Offering - The Manila Times
Microbot Medical Inc. Closes $13 Million Registered Direct Offering for Common Stock and Preferred Investment Options - Nasdaq
Strategic $13M Funding Fuels Microbot Medical's Robotics Innovation: LIBERTY® System Development Accelerates - StockTitan
Microbot Medical Announces $13 Million Registered Direct Offering - Defense World
Microbot Medical announces $13 million registered direct offering - MSN
Microbot Medical to Sell Common Stock Worth $13 Million -February 10, 2025 at 12:17 pm EST - Marketscreener.com
Microbot Medical announces $13M offering - Mass Device
Microbot Medical raises funds and anticipates FDA clearance By Investing.com - Investing.com Nigeria
Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - The Manila Times
Microbot Medical Inc. Announces Registered Direct Offering and Concurrent Private Placement Totaling Approximately $13 Million - Nasdaq
Pre-Market Rally Continues For Microbot Medical (MBOT) Stock - Stocks Telegraph
Microbot Medical Announces $13 Million Registered Direct Offering -February 10, 2025 at 08:03 am EST - Marketscreener.com
Microbot Medical Secures Critical $13M Funding to Accelerate Revolutionary Surgical Robot Launch - StockTitan
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Analyzing the Price-to-Earnings Ratio of Microbot Medical Inc (MBOT) - The News Heater
Microbot Medical executives receive salary increases and benefits - MSN
Microbot Medical executives receive salary increases and benefits By Investing.com - Investing.com Australia
Microbot Medical Enters Material Definitive Agreement - TipRanks
Microbot Medical Inc [MBOT] Revenue clocked in at $0.00 million, up 93.75% YTD: What’s Next? - The DBT News
Microbot Medical (NASDAQ: MBOT) Announces Acceptance of Late-Breaking Abstract for SIR Annual MeetingOn February 4, 2025, Microbot Medical Inc., a developer of the LIBERTY® Endovascular Robotic System, disclosed the acceptance of a late-breakin - Defense World
Microbot Medical files to sell about 16M shares of common stock by holders - MSN
Microbot Medical regains Nasdaq compliance with bid price - MSN
Microbot Medical Files Prospectus Relates To Resale From Time To Time Of Up To 15.97 Million Shares By Selling Stockholders - Marketscreener.com
Microbot Medical Presents LIBERTY System at Radiology Event - TipRanks
What was Microbot Medical Inc (MBOT)’s performance in the last session? - US Post News
Microbot Medical® Announces Late-Breaking Abstract - GlobeNewswire
Microbot Medical to Present Groundbreaking LIBERTY Robot Trial Data at SIR 2025 | MBOT Stock News - StockTitan
H.C. Wainwright analysts reiterates a Buy rating for Microbot Medical Inc (MBOT) - Knox Daily
Microbot Medical regains Nasdaq compliance with bid price By Investing.com - Investing.com Australia
Microbot Medical Inc (MBOT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.47%
0.19%
자본화:
|
볼륨(24시간):